The treatment of urinary-tract infections with an oral carbenicillin.

M. Turck
DOI: https://doi.org/10.1093/INFDIS/127.SUPPLEMENT_2.S133
1973-05-01
Abstract:An orally absorbed indanyl ester of carbenicillin was investigated in 26 patients with bacteriuria. The 26 patients, who were treated with 2.0 or 4.0 g of drug per day for 14 days, included 15 with Escherichia coli, five with Proteus, five with Pseudomonas, and one with Klebsiella bacteriuria. No serious adverse reactions to the drug were encountered although most patients noted a bitter taste. Bacteriuria was eradicated during therapy in 19 patients, including three infected with Pseudomonas. Concentrations of drug were determined in serum and urine of five subjects after administration of 500 or 1,000 mg of antibiotic. Although peak concentrations in the serum were low (less than 10 tg/ml), concentrations in the urine generally exceeded the minimal inhibitory concentrations for many Enterobacteriaceae and Pseudomonas.
What problem does this paper attempt to address?